European Journal of Applied Physiology

, Volume 91, Issue 2–3, pp 342–348 | Cite as

The serum angiotensin-converting enzyme and angiotensin II response to altered posture and acute exercise, and the influence of ACE genotype

  • David Woods
  • Julie Sanders
  • Alun Jones
  • Emma Hawe
  • Peter Gohlke
  • Steve E. Humphries
  • John Payne
  • Hugh Montgomery
Original Article


The deletion (D) rather than insertion (I) allele of the angiotensin-converting enzyme (ACE) gene is associated with greater ACE activity. We examined: (1) the influence of posture change (recumbent to seated) and acute exercise on serum ACE and angiotensin II (Ang II) activity; (2) the relationship between ACE and Ang II levels; and (3) the influence of ACE genotype on changes in ACE and Ang II levels with posture and exercise. Recreationally active young male Caucasians (10 each of II, ID and DD genotypes) rested for 35 min supine then 15 min upright, took 20 min bicycle ergometric exercise at 70% maximum oxygen uptake, then rested for 40 min. Samples were taken throughout for ACE activity and Ang II levels. Supine ACE levels were dependent upon ACE genotype [24.8 (5.7), 26.9 (4.5), 45.5 (6.4) nmol His-Leu ml−1 min−1; II, ID, DD, respectively; P<0.00005] and thereafter. ACE activity rose with assumption of a seated posture [from 32.4 (10.9) nmol His-Leu ml−1 min−1 to 35.0 (11.5) nmol His-Leu ml−1 min−1, P<0.00001], the absolute rise being independent of genotype [3.22 (1.92), 1.6 (1.6), 2.4 (2.3) nmol His-Leu ml−1 min−1; II, ID, DD; P=0.22], unlike percentage change [12.8 (6.8), 5.6 (5.5), 5.3 (5.0)%; II, ID, DD; P<0.01, and P=0.004 for II vs presence of the D allele]. A further genotype-independent rise occurred with exercise [+2.9 (3.7) units, P<0.0003]. An associated rise in Ang II levels [30.3 (15.9), or 2587.9 (489.76)%, P<0.00001] was independent of ACE genotype or activity. Upright posture increases ACE activity, and this may be influenced by ACE genotype. ACE activity and Ang II levels rise independently with exercise in a non-genotype-dependent fashion.


Angiotensin-converting enzyme Angiotensin Exercise Posture Genotype 



We should like to thank the volunteers who took part. J.S. and H.M. are funded by the Portex Endowment. This work was supported by an unconditional educational grant from Aventis UK. J.S., S.E.H. and J.R.P. are funded by the British Heart Foundation, who also provide core funding for the Centre for Cardiovascular Genetics. These experiments comply with the current United Kingdom law.


  1. Admiraal PJ, Derkx FH, Danser AH, Pieterman H, Schalekamp MA (1990) Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension 15:44–55PubMedGoogle Scholar
  2. Aldigier JC, Huang H, Dalmay F, Lartigue M, Baussant T, Chassain AP, Leroux-Robert C, Galen FX (1993) Angiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans. J Cardiovasc Pharmacol 21:289–295PubMedGoogle Scholar
  3. Arvay G, Szathmary G, Reuter M (1982) Changes in angiotensin-converting enzyme activity and angiotensin I level in asthmatic and healthy children after submaximal physical work. J Allergy Clin Immunol 69:178–180PubMedGoogle Scholar
  4. Beldent V, Michaud A, Wei L, Chauvet M-T, Corvol P (1993) Proteolytic release of human angiotensin-converting enzyme: localisation of the cleavage site. J Biol Chem 268:26428–26434PubMedGoogle Scholar
  5. Beneteau-Burnat B, Baudin B, Morgant G, Baumann FC, Giboudeau J (1990) Serum angiotensin-converting enzyme in healthy an sarcoidotic children: comparison with the reference interval for adults. Clin Chem 36:344–346PubMedGoogle Scholar
  6. Bouissou P, Guezennec CY, Galen FX, Defer G, Fiet J, Pesquies PC (1988) Dissociated response of aldosterone from plasma renin activity during prolonged exercise under hypoxia. Horm Metab Res 20:517–521PubMedGoogle Scholar
  7. Braith RW, Welsch MA, Feigenbaum MS, Kluess HA, Pepine CJ (1999) Neuroendocrine activation in heart failure is modified by endurance exercise training. J Am Coll Cardiol 34:1170–1175CrossRefPubMedGoogle Scholar
  8. Brown NJ, Blais C Jr, Gandhi SK, Adam A (1998) ACE insertion/deletion genotype affects bradykinin metabolism. J Cardiovasc Pharmacol 32:373–377CrossRefPubMedGoogle Scholar
  9. Chadwick IG, O’Toole L, Morice AH, Yeo WW, Jackson PR, Ramsay LE (1997) Pressor and hormonal responses to angiotensin I infusion in healthy subjects of different angiotensin-converting enzyme genotypes. J Cardiovasc Pharmacol 29:485–489CrossRefPubMedGoogle Scholar
  10. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F (1993) Angiotensin 1-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 290:33–40PubMedGoogle Scholar
  11. Danser AH, Maarten ADH, Schalekamp MADH, Bax WA, van den Brink AM, Saxena PR, Riegger GAJ, Schunkert H (1995) Angiotensin-converting enzyme in the human heart: effect of the deletion/insertion polymorphism. Circulation 92:1387–1388PubMedGoogle Scholar
  12. Danser AH, Deinum J, Osterop AP, Admiraal PJ, Schalekamp MA (1999) Angiotensin I to angiotensin II conversion in the human forearm and leg: effect of the angiotensin converting enzyme gene insertion/deletion polymorphism. J Hypertens 17:1867–1872PubMedGoogle Scholar
  13. Folland J, Leach B, Little T, Hawker K, Myerson S, Montgomery H, Jones D (2000) Angiotensin-converting enzyme genotype affects the response of human skeletal muscle to functional overload. Exp Physiol 85:575–579PubMedGoogle Scholar
  14. Freudenthaler SM, Lucht I, Schenk T, Brink M, Gleiter CH (2000) Dose-dependent effect of angiotensin II on human erythropoietin production. Pflugers Arch 439:838–844PubMedGoogle Scholar
  15. Fyhrquist F, Dessypris A, Immonen I (1983) Marathon run: effects on plasma renin activity, renin substrate, angiotensin converting enzyme, and cortisol. Horm Metab Res 15:96–99PubMedGoogle Scholar
  16. Gordon SE, Davis BS, Carlson CJ, Booth FW (2001) Ang II is required for optimal overload-induced skeletal muscle hypertrophy Am J Physiol Endocrinol Metab 280: E150–159Google Scholar
  17. Harp JB, Henry SA, DiGirolamo M (2002) Dietary weight loss decreases serum angiotensin-converting enzyme activity in obese adults. Obes Res 10:985–990PubMedGoogle Scholar
  18. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, Foy CJ, Watt GC (1993) The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 21:455–460PubMedGoogle Scholar
  19. Hilgenfeldt U, Puschner T, Riester U, Finsterle J, Hilgenfeldt JR (1998) Low-salt diet downregulates plasma but not tissue kallikrein-kinin system. Am J Physiol 275: F88–F93PubMedGoogle Scholar
  20. Jalil JE, Ocaranza MP, Piddo AM, Jalil R (1999) Reproducibility of plasma angiotensin-converting enzyme activity in human subjects determined by fluorimetry with Z-phenylalanine-histidyle-leucine as substrate. J Lab Clin Med 133:510–506Google Scholar
  21. Kem DC, Brown RD (1990) Renin–from beginning to end. N Eng J Med 323:1136–1137Google Scholar
  22. Kinugawa T, Ogino K, Miyakoda H, Saitoh M, Hisatome I, Fujimoto Y, Yoshida A, Shigemasa C, Sato R (1997) Responses of catecholamines, renin-angiotensin system, and atrial natriuretic peptide to exercise in untrained men and women. Gen Pharmacol 28:225–228CrossRefPubMedGoogle Scholar
  23. Kosunen KJ, Pakarinen AJ (1976) Plasma renin, angiotensin II, and plasma and urinary aldosterone in running exercise. J Appl Physiol 41:26–29PubMedGoogle Scholar
  24. Kraemer WJ, Fleck SJ, Maresh CM, Ratamess NA, Gordon SE, Goetz KL, Harman EA, Frykman PN, Volek JS, Mazzetti SA, Fry AC, Marchitelli LJ, Patton JF (1999) Acute hormonal responses to a single bout of heavy resistance exercise in trained power lifters and untrained men. Can J Appl Physiol 24:524–537PubMedGoogle Scholar
  25. Lee MA, Paul M, Bohm M, Ganten D (1992) Effects of angiotensin-converting enzyme inhibitors on tissue renin-angiotensin systems. Am J Cardiol 70:12C–19CPubMedGoogle Scholar
  26. Matsui T, Matsufuji H, Kawasaki T, Osajima Y (1997a) Determination of endogenous peptides with in vitro ACE inhibitory activity in normotensive human plasma by the fluorometric HPLC method. Biosci Biotechnol Biochem 61:1052–1054PubMedGoogle Scholar
  27. Matsui T, Matsufuji H, Tamaya K, Kawasaki T, Osajima Y (1997b) Metabolic behavior of angiotensins in normotensive human plasma in the supine and upright postures Biosci Biotechnol Biochem 61:1814–1818Google Scholar
  28. Metsarinne K (1988) Effect of exercise on plasma renin substrate. Int J Sports Med 9:267–269PubMedGoogle Scholar
  29. Milledge JS, Catley DM (1982) Renin, aldosterone, and converting enzyme during exercise and acute hypoxia in humans. J Appl Physiol 52:320–323PubMedGoogle Scholar
  30. Miura S, Ideishi M, Sakai T, Motoyama M, Kinoshita A, Sasaguri M, Tanaka H, Shindo M, Arakawa K (1994) Angiotensin II formation by an alternative pathway during exercise in humans. J Hypertens 12:1177–1181PubMedGoogle Scholar
  31. Montgomery HE, Clarkson P, Dollery CM, Prasad K, Losi M-A, Hemingway H, Statters D, Jubb M, Girvain M, Varnava A, World M, Deanfield J, Talmud P, McEwan JR, McKenna WJ, Humphries S (1997) Association of Angiotensin-Converting Enzyme Gene I/D polymorphism with change in left ventricular mass in response to physical training. Circulation 96:741–747PubMedGoogle Scholar
  32. Montgomery HE, Marshall RM, Hemingway H, Myerson S, Clarkson P, Dollery C, Hayward M, Holliman DE, Jubb M, World M, Thomas EL, Brynes AE, Saeed N, Barnard M, Bell JD, Prasad K, Rayson M, Talmud PJ, Humphries SE (1998) Human gene for physical performance. Nature 393:221–222PubMedGoogle Scholar
  33. Montgomery H, Humphries S, Danilov S (2002) Is genotype or phenotype the better tool for investigating the role of ACE in human cardiovascular disease? Eur Heart J 23:1083–1086CrossRefPubMedGoogle Scholar
  34. Musumeci V, Cardillo C, BaroniS, Tutinelli F, Guerrera G, Melina D, Savi L, Folli G (1987) Plasma markers of endothelial cells and platelet activation following handgrip in normals and hypertensive patients. J Clin Hypertens 3:487–499PubMedGoogle Scholar
  35. Novo S, Adamo L, Giamporcaro A, Forte G, Longo B, Gallo VB, Licata G, Strano A (1987) Changes of angiotensin converting enzyme (ACE) levels during activation of the renin-angiotensin-aldosterone system (RAAs). Agents Actions Suppl 22:339–347PubMedGoogle Scholar
  36. Nystrom F, Karlberg BE, Ohman KP (1997) Serum angiotensin-converting enzyme activity correlates positively with plasma angiotensin II: a population-based study of ambulatory blood pressure and the renin-angiotensin system. J Hum Hypertens 11:301–306CrossRefPubMedGoogle Scholar
  37. O’Dell SD, Humphries SE, Day IN (1995) Rapid methods for population-scale analysis for gene polymorphisms: the ACE gene as an example. Br Heart J 73:368–371PubMedGoogle Scholar
  38. Pluto R, Cruze SA, Weiss M, Hotz T, Mandel P, Weicker H (1988) Cardiocirculatory, hormonal, and metabolic reactions to various forms of ergometric tests. Int J Sports Med 9 [Suppl 2]:S79–88Google Scholar
  39. Ribichini F, Steffenino G, Dellavalle A, Matullo G, Colajanni E, Vado A, Bennetton G, Uslenghi E, Piazza A (1998) Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk of coronary stent restenosis. Circulation 97:147–154PubMedGoogle Scholar
  40. Sadhukhan R, Sen GC, Ramchandran R, Sen I (1998) The distal ectodomain of angiotensin-converting enzyme regulates its cleavage-secretion from the cell surface. Proc Natl Acad Sci USA 95:138–143CrossRefPubMedGoogle Scholar
  41. Santhamma KR, Sen I (2000) Specific cellular proteins associate with angiotensin-converting enzyme and regulate its intracellular transport and cleavage-secretion. J Biol Chem 275:23253–23258CrossRefPubMedGoogle Scholar
  42. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F (1992) Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin 1-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 51:197–205PubMedGoogle Scholar
  43. Ueda S, Elliott HL, Morton JJ, Connell JM (1995) Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 25:1266–1269PubMedGoogle Scholar
  44. Unger T, Schüll B, Rascher W, Lang RE, Ganten D (1982) Selective activation of the converting enzyme inhibitor MK 421 and comparison of its active diacid form with captopril in different tissues of the rat. Biochem Pharmacol 31:3063–3070CrossRefPubMedGoogle Scholar
  45. Williams AG, Rayson MP, Jubb M, World M, Woods DR, Hayward M, Martin J, Humphries SE, Montgomery HE (2000) The ACE gene and muscle performance. Nature 403:614CrossRefGoogle Scholar
  46. Woods DR, Brull D, Montgomery HE (2000) Endurance and the ACE I/D polymorphism. Sci Prog 83:317–336PubMedGoogle Scholar
  47. Xavier-Neto J, Pereira AC, Junqueira ML, Carmona R, Krieger JE (1999) Rat angiotensin-converting enzyme promoter regulation by beta-adrenergics and cAMP in endothelium. Hypertension 34:31–38PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • David Woods
    • 2
  • Julie Sanders
    • 1
  • Alun Jones
    • 1
  • Emma Hawe
    • 1
  • Peter Gohlke
    • 3
  • Steve E. Humphries
    • 1
  • John Payne
    • 1
  • Hugh Montgomery
    • 1
  1. 1.Centre for Cardiovascular GeneticsRoyal Free and University College London Medical SchoolLondonUK
  2. 2.Department of Diabetes and EndocrinologyFreeman HospitalNewcastle upon TyneUK
  3. 3.Institute of PharmacologyUniversity of KielKielGermany

Personalised recommendations